Milestone Scientific/MLSS

$0.57

0.22%
-
1D1W1MYTD1YMAX

About Milestone Scientific

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

Ticker

MLSS

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Jan Haverhals

Employees

17

Headquarters

Livingston, United States

MLSS Metrics

BasicAdvanced
$43.67M
Market cap
-
P/E ratio
-$0.09
EPS
0.96
Beta
-
Dividend rate
$43.67M
0.95715
$1.35
$0.52
74.48K
3.508
2.205
0.005
0.133
-55.68%
-75.98%
-73.81%
4.444
5.397
5.575
11.6%
23.35%
21.81%

What the Analysts think about MLSS

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 1 analyst.
426.32% upside
High $3.00
Low $3.00
$0.57
Current price
$3.00
Average price target

MLSS Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-86.36% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.2M
10%
Net income
$-1.9M
35.71%
Profit margin
-86.36%
23.37%

MLSS Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 50%
QuarterlyAnnual
Q1 23
Q2 23
Q1 24
Actual
-$0.02
-$0.03
-
Expected
-$0.03
-$0.02
-$0.02
Surprise
-33.33%
50%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Milestone Scientific stock?

Milestone Scientific (MLSS) has a market cap of $43.67M as of April 19, 2024.

What is the P/E ratio for Milestone Scientific stock?

The price to earnings (P/E) ratio for Milestone Scientific (MLSS) stock is 0 as of April 19, 2024.

Does Milestone Scientific stock pay dividends?

No, Milestone Scientific (MLSS) stock does not pay dividends to its shareholders as of April 19, 2024.

When is the next Milestone Scientific dividend payment date?

Milestone Scientific (MLSS) stock does not pay dividends to its shareholders.

What is the beta indicator for Milestone Scientific?

Milestone Scientific (MLSS) has a beta rating of 0.96. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Milestone Scientific stock price target?

The target price for Milestone Scientific (MLSS) stock is $3, which is 426.32% above the current price of $0.57. This is an average based on projections from 1 analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Milestone Scientific stock

Buy or sell Milestone Scientific stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing